Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 1
2018 2
2019 1
2020 1
2021 2
2022 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Results by year

Filters applied: . Clear all
Page 1
MicroRNAs in Tumor Cell Metabolism: Roles and Therapeutic Opportunities.
Pedroza-Torres A, Romero-Córdoba SL, Justo-Garrido M, Salido-Guadarrama I, Rodríguez-Bautista R, Montaño S, Muñiz-Mendoza R, Arriaga-Canon C, Fragoso-Ontiveros V, Álvarez-Gómez RM, Hernández G, Herrera LA. Pedroza-Torres A, et al. Among authors: rodriguez bautista r. Front Oncol. 2019 Dec 11;9:1404. doi: 10.3389/fonc.2019.01404. eCollection 2019. Front Oncol. 2019. PMID: 31921661 Free PMC article. Review.
Long non-coding RNAs: implications in targeted diagnoses, prognosis, and improved therapeutic strategies in human non- and triple-negative breast cancer.
Rodríguez Bautista R, Ortega Gómez A, Hidalgo Miranda A, Zentella Dehesa A, Villarreal-Garza C, Ávila-Moreno F, Arrieta O. Rodríguez Bautista R, et al. Clin Epigenetics. 2018 Jun 27;10:88. doi: 10.1186/s13148-018-0514-z. eCollection 2018. Clin Epigenetics. 2018. PMID: 29983835 Free PMC article. Review.
Characterization of triple negative breast cancer gene expression profiles in Mexican patients.
Ortiz Valdez E, Rangel-Escareño C, Matus Santos JA, Vázquez Romo R, Guijosa A, Villarreal-Garza C, Arrieta O, Rodríguez-Bautista R, Caro-Sánchez CH, Ortega Gómez A. Ortiz Valdez E, et al. Among authors: rodriguez bautista r. Mol Clin Oncol. 2022 Dec 15;18(1):5. doi: 10.3892/mco.2022.2601. eCollection 2023 Jan. Mol Clin Oncol. 2022. PMID: 36605097 Free PMC article.
Immune Milieu and Genomic Alterations Set the Triple-Negative Breast Cancer Immunomodulatory Subtype Tumor Behavior.
Rodríguez-Bautista R, Caro-Sánchez CH, Cabrera-Galeana P, Alanis-Funes GJ, Gutierrez-Millán E, Ávila-Ríos S, Matías-Florentino M, Reyes-Terán G, Díaz-Chávez J, Villarreal-Garza C, Hernández-Pedro NY, Ortega-Gómez A, Lara-Mejía L, Rangel-Escareño C, Arrieta O. Rodríguez-Bautista R, et al. Cancers (Basel). 2021 Dec 13;13(24):6256. doi: 10.3390/cancers13246256. Cancers (Basel). 2021. PMID: 34944876 Free PMC article.
The efficacy of first-line chemotherapy in endocrine-resistant hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-) metastatic breast cancer.
Chainitikun S, Long JP, Rodriguez-Bautista R, Iwase T, Tripathy D, Fujii T, Ueno NT. Chainitikun S, et al. Among authors: rodriguez bautista r. Breast Cancer Res Treat. 2020 Oct;183(3):729-739. doi: 10.1007/s10549-020-05837-6. Epub 2020 Jul 27. Breast Cancer Res Treat. 2020. PMID: 32720114 Free PMC article.